Skip to Main Content

Paper Details

Can Preferentially Prescribing Angiotensin II Receptor Blockers (ARBs) over Angiotensin-Converting Enzyme Inhibitors (ACEIs) Decrease Dementia Risk and Improve Brain Health Equity?
NAM Perspect
3
2022
Author NameAffiliation
Eric B LarsonKaiser Permanente Washington Health Research Institute.
Jeff D WilliamsonWake Forest School of Medicine.
  • 1 - 2

Datasets

Release 1.2